Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-28

Clinical Trial Update: An Open Label Study for Palmar Hyperhydrosis [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial completed for palmar hyperhidrosis evaluating an intervention to reduce excessive sweating.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pariser, Robert J., M.D. | Conditions: Palmar Hyperhidrosis, Hyperhidrosis | Phase 2 | Status: COMPLETED